Siyanotik Konjenital Kalp Hastalarında Sistemik-Pulmoner Şant Teknikleri: 24 Yıllık Klinik Deneyimin Analizi

Year 2023, Volume: 37 Issue: 2, 173 - 189, 06.09.2023

Burcu Bıçakhan Aybala Tongut İlhan Özgöl Alican Hatemi

https://doi.org/10.18614/deutip.1181487

Abstract

Amaç: Aortopulmoner şant operasyonları, kompleks siyanotik kalp hastalıklarında pulmoner kan akımının arttırılması ve pulmoner arterlerin gelişmesi, dolayısı ile sistemik oksijen saturasyonunun iyileştirilmesini amaçlayan palyatif prosedürlerdir. Çalışmadaki amaç, palyatif aortopulmoner şant operasyonu uygulanan hastalarda preoperatif durum, operatif teknik ve yaklaşımlar ile postoperatif seyir arasındaki ilişkileri tespit etmek, mortalite ve morbiditeye etki eden risk faktörlerini araştırmak ve değerlendirmektir.
Gereç ve yöntemler: Çalışmaya Kasım 1985-Ağustos 2009 tarihleri arasında İstanbul Üniversitesi Kardiyoloji Enstitüsü Kalp Damar Cerrahisi Anabilim Dalı’nda Modifiye Blalock-Taussig şant (MBTS) operasyonu uygulanan 587 olgu dahil edildi. Retrospektif olarak preoperatif ve operatif veriler kaydedilerek, hastalar patofizyolojinin tek ya da çift ventrikül tamirine uygunluğu temel alınarak (univentrikül/biventrikül) iki grupta sınıflandırıldı. Birincil sonuç olarak hastane ölümü veya iyi hal ile taburcu olma kabul edildi. Yaş grupları (neonatal, 1 ay-1 yaş ve 1 yaş üzeri) ve cerrahi yaklaşım (torakotomi, sternotomi) temel alınarak, yaklaşımlar arasındaki farkların birincil sonuç üzerine etkisi değerlendirildi. Mortalite ve morbidite üzerine etki eden risk faktörleri istatistiksel olarak araştırıldı.
Bulgular: Çalışmaya katılan 364’ü erkek (%62), 223’ü kız (%38), ortalama yaşı 21,6±31,2 ay (0-240) ve ortalama kilosu 10.7±7.2 kg (2.7-54) olan 587 hastanın, 66'sı1 aylık (%11.2), 236'sı 1 ay-1 yaş (%40.2) ve 285'i 1 yaş üzeri (%48.6) grupta değerlendirilmiştir. Yüzdoksanbir hastada univentriküler (%32.5) ve 396 hastada biventriküler (%67.5) tamir planlanmış, 141 hastada median sternotomi (%24), 446 hastada torakotomi (%76) uygulanmıştır. Erken dönem mortalite oranı %11.6’dır. Şant yetmezliği açısından; yaş, tanı, ekstrakorporeal dolaşım (ECC) kullanım ihtiyacı, cerrahi yaklaşım, şant çapı anlamlı bulunmuş ve çoklu değişken lojistik regresyon analizi sonucunda cerrahi yaklaşım bağımsız risk faktörü olarak saptanmıştır (p=0.002). Mortalite açısından anlamlı bulunan yaş, şant çapı ve cerrahi yaklaşım arasında lojistik regresyon analizi ile sternotomi (p=0.0001) ve 1 ay-1 yas arası grup (p=0,008) bağımsız risk faktörü olarak izlenmiştir.
Sonuç: Halen özellikle kompleks konjenital kalp hastalıklarında palyatif cerrahinin altenatif yaklaşımlarının azlığı sebebi ile kalp cerrahisindeki yerini koruyacağı görülmektedir. Günümüzde MBTS prosedürü için cerrahi yaklaşımlar ve yoğun bakım takip protokollerinde geniş bir bilgi birikimi ve deneyim edinilmiş olsa bile, bu hasta grubunda mortalite ve morbiditeye etkili risk faktörlerini uzun dönem sonuçları ile araştıran prospektif çalışmalara ihtiyaç vardır.

Keywords

Konjenital kalp hastalığı, Siyanotik, Palyatif işlem, Şant

Systemic to Pulmonary Shunt Techniques in Cyanotic Congenital Heart Disease Patients: An Analysis of 24 Years of Clinical Experience

Abstract

Purpose: Aortopulmonary shunt operations are palliative interventions that are used in complex cyanotic cardiac conditions to improve systemic oxygen saturation and maturating pulmonary arteries by increasing pulmonary blood flow. In this study, we aimed to investigate and evaluate the association between preoperative conditions, operative techniques, and postoperative outcomes; as well as to determine the risk factors that are related to morbidity, and mortality in patients receiving palliative aortopulmonary shunt procedures.
Material and methods: Five hundred eighty-seven patients who underwent MBTS operation in Istanbul University, Institute of Cardiology, Department of Cardiovascular Surgery between November 1985 – August 2009 were included in the study. Preoperative and postoperative data were examined, and patients were retrospectively grouped into two, regarding their pathology for either univentricular, or biventricular repair. Primary outcome was investigated as means of in-hospital death, or being discharged in good health. Three age groups (neonatal, 1 month-1 year, older than 1 year), and two surgical technique groups (thoracotomy, sternotomy) were established to determine their effects on primary outcomes. Risk factors for mortality and morbidity were statistically analyzed.
Results: Among the 587 patients enrolled, 364 were male (%62), and 223 were female (%38). Average age and body weights were 21,6±31,2 months (0-240 months), and 10,7±7,2 kg (2,7–54 kg), respectively. Age groups were as follows: 66 were under 1 month (%11,2), 236 were between 1 month and 1 year (%40,2), 285 were over 1 year (%48,6). One hundred ninety-one cases (%32,5) underwent univentricular repair, and biventricular repair procedure was planned for the remaining 396 patients (%67,5). Median sternotomy was the approach preferred for 141 patients (%24) and thoracotomy for the other 446 (%76). Early mortality rates were calculated as %11,6. Age, diagnosis, use of ECC, surgical approach and shunt diameter were found to be important risk factors for shunt failure. Among those, only surgical approach was found to be an independent risk factor according to multi-variate logistic regression analysis (p=0,002). Among mortality factors found to be statistically significant such as age, shunt diameter, and surgical technique, only sternotomy (p=0,0001) and being between 1month – 1 year of age (p=0,008) were considered to be independent risk factors.
Conclusion: In complex congenital heart defects, palliative surgical treatment seems to be the primary approach due to lack of alternatives. Today, there is an extensive experience on MBTS procedure and on its intensive care follow up protocools but there is still a need for long term prospective trials to establish the risk factors affecting mortality, and morbidity.

Keywords

Congenital heart disease, Cyanotic, Palliative procedure, Shunt

References

• 1. Mavroudis C, Backer CL. Pediatric Cardiac Surgery. 3rd ed. Pennsylvania: Mosby; 2003: 160-70
• 2. Yuan SM, Shinfeld A, Raanani E. 7. The Blalock-Taussig shunt. Card Surg 2009; 24: 101-8.
• 3. Evans WN. The Blalock-Taussig shunt: the social history of an eponym. Cardiol Young 2009; 19: 119-28.
• 4. Williams JA, Bansal AK, Kim BJ, Nwakanma LU, Patel ND, Seth AK ve ark. Two Thousand Blalock-Taussig Shunts: A Six-Decade Experience. Ann Thorac Surg 2007; 84(6): 2070-5.
• 5. Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The modified Blalock-Taussig shunt: Clinical impact and morbidity in Fallot’s tetralogy in the current era. J Thorac Cardiovasc Surg 1997; 114: 25-30.
• 6. Rana JS, Ahmad KA, Shamim AS, Hassan SB, Ahmed MA. Blalock-Taussig shunt: experience from the developing world. Heart Lung Circ 2002; 11(3):152-6.
• 7. Fermanis GG, Ekangaki AK, Salmon AP ve ark. Twelve year experience with the modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg 1992; 6: 586-9.
• 8. Al Jubair KA, Al Fagih MR, Al Jarallah AS, Al Yousef S, Ali Khan MA, Ashmeg A ve ark. Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young 1998 Oct; 8(4): 486-90.
• 9. Norwood WI, Lang P, Hansen DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med 1983; 308: 23.
• 10. Glenn WWL. Circulatory bypass of the right side of the heart. IV. Shunt between superior vena cava and distal right pulmonary artery, report of a clinical application. N Engl J Med 1958; 259; 117.
• 11. Moulton AL, Brenner JI, Ringel R, Nordenberg A, Berman MA, Ali S ve ark. Classic versus modified Blalock-Taussig’s shunts in neonates and infants. Circulation 1985; 72: II35-44.
• 12. De Leval MR, McKay R, Jones M, Stark J, Macartney FJ. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg 1981; 81: 112–9.
• 13. Corno AF, Hurni M, Payot M ve ark. Modified Blalock-Taussig shunt with compensatory properties. Ann Thorac Surg 1999; 67: 269-70.
• 14. Odim J, Portzky M, Zurakowski D, Wernovsky G, Burke RP, Mayer JE ve ark. Sternotomy approach for the modified Blalock-Taussig shunt. Circulation 1995; 92: 256–61.
• 15. Mittal PK. Transaxillary minithoracotomy for modified Blalock-Taussig shunt. Ann Thorac Surg 1997; 64: 269-70.
• 16. Alkhulaifi AM, Lacour-Gayet F, Serraf A, Belli E, Planché C. Systemic pulmonary shunts in neonates: early clinical outcome and choice of surgical approach. Ann Thorac Surg 2000; 69: 1499-504.
• 17. Horiguchi Y, Hiraishi S, Misawa H ve ark. Cross sectional and Doppler echocardiographic evaluation of aortopulmonary shunts. Br Heart J 1992; 67: 312-5.
• 18. Blalock A, Taussig HB. The surgical treatment of malformations of the heart in which there is pulmoner stenosis or pulmoner atresia. JAMA 1945; 128: 129.
• 19. Ullom RL, Sade RM, Crawford FA Jr, Ross BA, Spinale F. The Blalock-Taussig shunt in infants: standard versus modified. Ann Thorac Surg 1987; 44(5): 539-43.
• 20. Kandakure PR, Dharmapuram AK, Ramadoss N, Babu V, Rao IM, Murthy KS. Sternotomy approach for modified Blalock-Taussig shunt: is it a safe option? Asian Cardiovasc Thorac Ann 2010; 18(4): 368-72.
• 21. Tamisier D, Vouhe PR, Vernant F, Leca F, Massot C, Neveux J-Y. Modified Blalock-Taussig shunts: results in infants less than 3 months of age. Ann Thorac Surg. 1990; 49: 797-801.
• 22. Chang RK, Rodriguez S, Lee M, Klitzner TS. Risk factors for deaths occurring within 30 days and 1 year after hospital discharge for cardiac surgery among pediatric patients. Am Heart J 2006; 152(2): 386-93.
• 23. Lamberti JJ, Carlisle J, Waldman JD, Lodge FA, Kirkpatrick SE, George L ve ark. Systemic-pulmonary shunts in infants and children. Early and late results. J Thorac Cardiovasc Surg 1984; 88(1): 76-81.
• 24. Ahmad U, Fatimi SH, Naqvi I, Atiq M, Moizuddin SS, Sheikh KB ve ark. Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates. Heart Lung Circ 2008; 17: 54-8.
• 25. Rao MS, Bhan A, Talwar S, Sharma R, Choudhary SK, Airan B ve ark. Modified Blalock-Taussing shunt in neonates: determinants of immediate outcome. Asian Cardiovasc Thorac Ann 2000; 8: 339-43.
• 26. Gold JP, Violaris K, Engle MA, Klein AA, Ehlers KH, Lang SJ ve ark. A five-year clinical experience with 112 Blalock-Taussig shunts. J Card Surg 1993; 8: 9 –17.
• 27. Arciniegas E, Farooki ZQ, Hakimi M, Perry BL, Green EW. Classic shunting operations for congenital cyanotic heart defects. J Thorac Cardiovasc Surg 1982; 84(1): 88-96.
• 28. Tsai KT, Chang CH, Lin PJ. Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome. J Cardiovasc Surg 1996; 37: 149-52.
• 29. Swain SK, Dharmapuram AK, Reddy P, Ramdoss N, Raghavan SS, Kona SM. Neonatal Blalock-Taussig shunt: technical aspects and postoperative management. Asian Cardiovasc Thorac Ann 2008; 16: 7–10.
• 30. Ibawi MN, Grieco J, DeLeon SY, Idriss FS, Muster AJ, Berry TE ve ark. Modified Blalock-Taussig shunt in newborn infants. J Thoracic Cardiovasc Surg 1984; 88: 770-5.
• 31. Erek E, Yalçınbaş YK, Mamur Y, Salihoğlu E, Turan T, Çolakoğu A. ve ark. Systemic-to-pulmonary shunt operation in neonates with ductus-dependent pulmonary blood flow. Türk Göğüs Kalp Damar Cer. Derg. 2007; 15(1): 29-35.
• 32. Sivakumar K, Shivaprakasha K, Rao SG, Kumar RK. Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts. Indian Heart J 2001; 53: 66–70.
• 33. Mullen JC, Lemermeyer G, Bentley MJ. Modified Blalock-Taussig shunts: to heparinize or not to heparinize? Can J Cardiol 1996; 12: 645–7.
• 34. Chantepie A, Cheliakine-Chamboux C, Aupart M, Bry P, Vaillant MC, Marchand M. Systemic pulmonary shunts in the neonatal period. Short and medium-term results. Arch Mal Coeur Vaiss 1995; 88: 693–8.
• 35. Godart F, Qureshi SA, Simha A, Deverall PB, Anderson DR, Baker EJ ve ark. Effects of modified and classic Blalock-Taussig shunts on the pulmonary arterial tree. Ann Thorac Surg 1998; 66: 512-18.
• 36. Kutsal A, Günay İ, Paşaoğlu İ, Hatipoğlu A, Demircin MN, Bozer AY. Klasik ve Modifiye Blalock-Taussig Şant Ameliyatları ve Sonuçları. Türkiye Klinikleri J Cardiol 1991; 4(3): 206-10.
• 37. McKay R, de Leval MR, Rees P, Taylor JFN, Macartney FJ, Stark J. Postoperative angiographic assessment of modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (Gore-Tex). Ann Thorac Surg 1980; 30: 137–43.
• 38. Fenton KN, Siewers RD, Rebovich B, Pigula FA. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg 2003; 76: 152-7.
• 39. Karpawich PP, Bush CP, Antillon JR, Amato JJ, Marbey ML, Agarwal KC. Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment. J Thorac Cardiovasc Surg 1985; 89: 275-9.
• 40. Kandakure PR, Dharmapuram AK, Ramadoss N, Babu V, Rao IM, Murthy KS. Sternotomy approach for modified Blalock-Taussig shunt: is it a safe option? Asian Cardiovasc Thorac Ann 2010; 18(4): 368-72.
• 41. Shauq A, Agarwal V, Karunaratne A, Gladman G, Pozzi M, Kaarne M ve ark. Surgical approaches to the blalock shunt: does the approach matter? Heart Lung Circ 2010; 19(8): 460-64.
• 42. Amato JJ, Marbey ML, Bush C, Galdieri RJ, Cotroneo JV, Bushong J. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. J Thorac Cardiovasc Surg 1988; 95: 62-9.
• 43. Mohammadi S, Benhameid O, Campbell A, Potts J, Joza J, Al-Habib H ve ark. Could we still improve early and interim outcome after prosthetic systemic-pulmonary shunt? A risk factors analysis. Eur J Cardiothorac Surg. 2008; 34(3): 545-9.
• 44. Chetpaophan A, Rergkliang C, Chittitavorn V, Vasinanukorn P. Early outcome of palliative shunt surgery for cyanotic congenital heart disease in Songklanagarind Hospital. Songkla Med J 2005; 23(3): 137-43.
• 45. Januszewska K, Kolcz J, Mroczek T, Procelewska M, Malec E. Right ventricle-to-pulmonary artery shunt and modified Blalock–Taussig shunt in preparation to hemi-Fontan procedure in children with hypoplastic left heart syndrome. Eur J Cardiothorac Surg 2005; 27: 956–61.
• 46. Petrucci O, O'Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg 2011; 92(2): 642-51.
• 47. Dirks V, Prêtre R, Knirsch W, Valsangiacomo Buechel ER, Seifert B, Schweiger M ve ark. Modified Blalock Taussig shunt: a not-so-simple palliative procedure. Eur J Cardiothorac Surg 2013; 44(6): 1096-102
• 48. Moszura T, Zubrzycka M, Michalak KW, Rewers B, Dryzek P, Moll JJ ve ark. Acute and late obstruction of a modified Blalock-Taussig shunt: a two-center experience in different catheter-based methods of treatment. IntInteract Cardiovasc Thorac Surg 2010; 10(5): 727-31.
• 49. Opie JC, Traverse L, Hayden RI, Ho CY, Culham JAG, Ashmore PG. Experience with polytetrafluoroethylene grafts in children with cyanotic congenital heart disease. Ann Thorac Surg 1986; 41: 164-8.
• 50. Calder AL, Chan NS, Clarkson PA, Alan RK, John MN. Progress of patients with pulmonary atresia after systemic to pulmonary arterial shunts. Ann Thorac Surg 1991; 51(3): 401-7.
• 51. Li JS, Yow E, Berezny KY, Rodes JF, Bokesch PM, Charpie JR ve ark. Clinical outcomes ofpalliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: Does aspirin make a difference?. Circulation 2007; 116: 293–7.
• 52. Wells WJ, Yu RJ, Batra AS, Monforte H, Sintek C, Starnes VA. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg 2005; 79(6): 2072-6.
• 53. Fenton KN, Pigula FA, Gandhi SK, Russo L, Duncan KF. Interim mortality in pulmonary atresia with intact ventricular septum. Ann Thorac Surg 2004; 78(6): 1994-8
• 54. Rao PS. Diagnosis and management of cyanotic congenital heart disease: part I. Indian J Pediatr. 2009; 76(1): 57-70.
• 55. Gedicke M, Morgan G, Parry A, Martin R, Tulloh R. Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations. Heart Vessels 2010; 25: 405-9.
• 56. Motz R, Wessel A, Ruschewski W, Bursch J. Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving aspirin. Cardiol Young 1999; 9: 474-7
• 57. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P ve ark. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6): 887-968.